
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.
Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals is an episode from FierceBiotech Radio. Fierce editors discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Feb 18, 2016, 39:23 long, audio available.